Literature DB >> 21824378

A systematic review of vaccinations to reduce the shedding of Escherichia coli O157 in the faeces of domestic ruminants.

K G Snedeker1, M Campbell, J M Sargeant.   

Abstract

The objective of this study was to conduct a systematic review and meta-analysis of the published literature to evaluate the efficacy of vaccines in reducing faecal shedding of Escherichia coli O157 in ruminants. A systematic search of eight databases and land-grant university research reports using an algorithm adapted from a previous systematic review of pre-harvest interventions against E. coli O157 was conducted to locate all reports of in vivo trials of E. coli O157 vaccines in ruminants published between 1990 and 2010. All located references were screened by two independent reviewers, and data were extracted from all relevant papers, with treatment effect measured in odds ratios. For trials with a faecal prevalence outcome that did not involve mixing of treated and untreated cattle in the same pen, efficacy was explored using random-effects meta-analysis. Funnel plots were used to evaluate publication bias, and random-effects meta-regression was performed to explore heterogeneity. The search located 20 relevant manuscripts which detailed 24 trials and 46 treatment comparisons; all but one trial involved cattle. There were 9 deliberate challenge trials (19 comparisons), and 15 natural exposure trials (27 comparisons). For Type III protein vaccines, there were 9 natural exposure trials detailing 17 comparisons, and meta-analysis of 8 comparisons revealed that vaccine treatment resulted in a statistically significant reduction in E. coli O157 faecal prevalence [odds ratio (OR)=0.38, 95% confidence interval (CI)=0.29, 0.51]. Siderophore receptor and porin protein (SRP) vaccines (three trials/four comparisons) also reduced faecal prevalence (OR=0.42, 95% CI=0.20, 0.61); however, none of the bacterin vaccine trials (n=3, six comparisons) resulted in a statistically significant reduction in prevalence. The results suggest that Type III protein and SRP vaccines significantly reduce faecal shedding in cattle; however, caution should be taken in interpreting the results because of the heterogeneity in the results.
© 2011 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824378     DOI: 10.1111/j.1863-2378.2011.01426.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  23 in total

1.  Strain-dependent cellular immune responses in cattle following Escherichia coli O157:H7 colonization.

Authors:  Alexander Corbishley; Nur Indah Ahmad; Kirsty Hughes; Michael R Hutchings; Sean P McAteer; Timothy K Connelley; Helen Brown; David L Gally; Tom N McNeilly
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 2.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Shiga Toxin-Producing E. coli in Animals: Detection, Characterization, and Virulence Assessment.

Authors:  Stefanie A Barth; Rolf Bauerfeind; Christian Berens; Christian Menge
Journal:  Methods Mol Biol       Date:  2021

4.  Exploiting the power of OMICS approaches to produce E. coli O157 vaccines.

Authors:  Anjana Kalita; Mridul Kalita; Alfredo G Torres
Journal:  Gut Microbes       Date:  2014

Review 5.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Protective efficacy and pharmacokinetics of human/mouse chimeric anti-Stx1 and anti-Stx2 antibodies in mice.

Authors:  Angela R Melton-Celsa; H M Carvalho; Claire Thuning-Roberson; A D O'Brien
Journal:  Clin Vaccine Immunol       Date:  2015-02-25

7.  Predicting the public health benefit of vaccinating cattle against Escherichia coli O157.

Authors:  Louise Matthews; Richard Reeve; David L Gally; J Chris Low; Mark E J Woolhouse; Sean P McAteer; Mary E Locking; Margo E Chase-Topping; Daniel T Haydon; Lesley J Allison; Mary F Hanson; George J Gunn; Stuart W J Reid
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

8.  Repeated Oral Vaccination of Cattle with Shiga Toxin-Negative Escherichia coli O157:H7 Reduces Carriage of Wild-Type E. coli O157:H7 after Challenge.

Authors:  Smriti Shringi; Haiqing Sheng; Carolyn J Hovde; Thomas E Besser; Andrew A Potter; Scott A Minnich
Journal:  Appl Environ Microbiol       Date:  2021-01-04       Impact factor: 4.792

9.  Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7.

Authors:  Víctor A García-Angulo; Anjana Kalita; Mridul Kalita; Luis Lozano; Alfredo G Torres
Journal:  Infect Immun       Date:  2014-03-04       Impact factor: 3.441

10.  'Super' or just 'above average'? Supershedders and the transmission of Escherichia coli O157:H7 among feedlot cattle.

Authors:  Simon E F Spencer; Thomas E Besser; Rowland N Cobbold; Nigel P French
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.